Literature DB >> 8821206

Influence of high-dose antithrombin concentrate therapy on the release of cellular proteinases, cytokines, and soluble adhesion molecules in acute inflammation.

M Jochum1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8821206

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  5 in total

Review 1.  Antithrombin III and sepsis.

Authors:  E F Mammen
Journal:  Intensive Care Med       Date:  1998-07       Impact factor: 17.440

2.  Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study.

Authors:  F Baudo; T M Caimi; F de Cataldo; A Ravizza; S Arlati; G Casella; D Carugo; G Palareti; C Legnani; L Ridolfi; R Rossi; A D'Angelo; L Crippa; D Giudici; G Gallioli; A Wolfler; G Calori
Journal:  Intensive Care Med       Date:  1998-04       Impact factor: 17.440

3.  Cardiovascular resistance to thrombosis in 13-lined ground squirrels.

Authors:  Alison Bonis; Leah Anderson; Gaëlle Talhouarne; Emily Schueller; Jenna Unke; Catherine Krus; Jordan Stokka; Anna Koepke; Brittany Lehrer; Anthony Schuh; Jeremiah J Andersen; Scott Cooper
Journal:  J Comp Physiol B       Date:  2018-10-13       Impact factor: 2.200

4.  The effect of Antithrombin-III on routine hematological and biochemical parameters in an experimental animal model of skeletal muscle ischemia-reperfusion injury.

Authors:  Dg Karamanos; Cd Karkos; Ag Kambaroudis; M Kritsepi; S Papadopoulos; Ct Spyridis; Ts Gerassimidis
Journal:  Hippokratia       Date:  2014 Jul-Sep       Impact factor: 0.471

Review 5.  Antithrombin III for critically ill patients.

Authors:  Mikkel Allingstrup; Jørn Wetterslev; Frederikke B Ravn; Ann Merete Møller; Arash Afshari
Journal:  Cochrane Database Syst Rev       Date:  2016-02-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.